Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
NCT03211377
·
clinicaltrials.gov ↗
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Esophagogastric Junction Cancer
Sponsor
Anyang Tumor Hospital